Alliancebernstein LP Stake in Johnson & Johnson (JNJ) Decreased by $84.67 Million as Shares Declined

April 20, 2018 - By Julia Strobel

Johnson & Johnson (NYSE:JNJ) Corporate LogoDuring 2017 Q4 the big money sentiment increased to 0.87. That’s change of 0.04, from 2017Q3’s 0.83. 35 investors sold all, 884 reduced holdings as JNJ ratio increased. 654 grew positions while 143 funds took positions. Funds hold 1.72 billion shares thus 0.40% more from 2017Q3’s 1.71 billion shares. Excalibur Management Corporation owns 49,842 shs. 3,285 were accumulated by Polaris Greystone Fincl Grp Limited Liability Company. First Hawaiian Comml Bank invested 0.1% in Johnson & Johnson (NYSE:JNJ). Dynamic Capital Mngmt invested 0.4% of its capital in Johnson & Johnson (NYSE:JNJ). Night Owl Capital Mgmt Limited Liability Corp reported 0.21% stake. The New York-based Rmsincerbeaux Cap Mgmt Ltd Com has invested 0.42% in Johnson & Johnson (NYSE:JNJ). Strategy Asset Managers Ltd Com owns 2.47% invested in Johnson & Johnson (NYSE:JNJ) for 90,350 shs. Lawson Kroeker Invest Mgmt Ne has 90,838 shs for 4.08% of their capital. Legacy Prtnrs has invested 2.85% of its capital in Johnson & Johnson (NYSE:JNJ). Weik Capital Mngmt has invested 2.56% in Johnson & Johnson (NYSE:JNJ). Hoertkorn Richard Charles reported 11,795 shs. Wallington Asset Llc accumulated 90,540 shs or 3.25% of the stock. Fernwood Investment Ltd Liability Corp has invested 1.47% in Johnson & Johnson (NYSE:JNJ). Virginia Retirement Sys Et Al, Virginia-based fund reported 1.08M shs. Banque Pictet And Cie Sa invested 2.82% in Johnson & Johnson (NYSE:JNJ).

JNJ had 1 insider sale and 0 buys since February 15, 2018. This’s net activity of $20.17 million.

In Johnson & Johnson (JNJ) was decreased the holdings owned by Alliancebernstein Lp. The decrease is 5.9% according to 2017Q4 SEC form. The company’s stock sank 9.21% while Alliancebernstein Lp sold 609,172 shares. The hedge fund is holding 9.71 million shares, compared to the 10.32M from the previous quarter. And the reported value of the major pharmaceuticals company is $1.36B for the 2017Q4. $341.65 billion is Johnson & Johnson’s MC. JNJ is touching $127.36 during the last trading session, after decreased 0.15%.Johnson & Johnson has volume of 1.64M shares. Since April 20, 2017 JNJ has risen 1.12% and is uptrending. The stock underperformed the S&P 500 by 10.43%.

Alliancebernstein Lp operates about $139.80B US Long portfolio. According to a filing the fund increased its stake in Twitter Inc (NYSE:TWTR) by 126,633 shares to 729,095 shares, valued at $17.51M in 2017Q4. For a total of 2.02M shares it increased its holding in Trinseo S A (NYSE:TSE) by 116,191 shares in the quarter, and has risen its stake in Logmein Inc (NASDAQ:LOGM).

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

In total 10 analysts cover Johnson \u0026 Johnson (NYSE:JNJ). “Buy” rating has 5, “Sell” are 1, while 4 are “Hold”. (NYSE:JNJ) has 50% bullish analysts. With $170.0 highest and $110.0 lowest target, Johnson \u0026 Johnson has $143.88 average target or 12.97% above the current ($127.36) price. 17 are the (NYSE:JNJ)’s ratings reports on Apr 20, 2018 according to StockzIntelligence Inc. On Thursday, April 12 the firm has “Buy” rating by Credit Suisse given. On Tuesday, February 6 Wells Fargo maintained Johnson & Johnson (NYSE:JNJ) rating. Wells Fargo has “Buy” rating and $160.0 target. On Monday, February 26 Jefferies maintained the shares of JNJ in report with “Buy” rating. On Tuesday, January 16 the firm earned “Buy” rating by Jefferies. The stock rating was maintained by Morgan Stanley with “Equal-Weight” on Tuesday, April 10. On Friday, March 23 the rating was maintained by Jefferies with “Buy”. On Monday, October 23 Citigroup maintained the shares of JNJ in report with “Buy” rating. The company rating was maintained by Stifel Nicolaus on Wednesday, April 18. In Tuesday, February 27 report Citigroup maintained the stock with “Neutral” rating. On Tuesday, January 2 the firm has “Neutral” rating by JP Morgan given.

Johnson & Johnson (NYSE:JNJ) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.